Market Overview

Abacus Health Reports Q3 Results, Expands Pharmacy Presence

Abacus Health Reports Q3 Results, Expands Pharmacy Presence

Abacus Health Products Inc (OTC: ABAHF) (CSE:ABCS) on Thursday announced financial results for the third quarter, with a revenue of $4.1 million, 26.4% higher than the second quarter.

Gross profit grew 100% year-over-year to $2.4 million and 24% from the second quarter. Gross margin remained almost flat at 60.1%, up by just 0.8% compared with the second quarter.

See Also: A Q&A With Abacus Health Products, The CBD Company Backed By Rob Gronkowski

Abacus Health also disclosed it has received a purchase order from a major national pharmacy chain in the United States, which will be offering its CBDMEDIC product line. Under this new supply agreement, the products will be available across 2,400 retail stores.

“This is a huge win for Abacus and its consumer product line, CBDMEDIC. The recent announcements we’ve made regarding retail store growth are indicative of the inflection point we’ve been waiting for and we expect acceleration in the adoption of our products by the F/D/M channel in the next several quarters,” said Perry Antelman, CEO of Abacus.

The stock was up 6.9% at $3.80 at time of publication.

Posted-In: Cannabis Earnings News Markets


Related Articles (ABAHF)

View Comments and Join the Discussion!

Cannabis Movers

Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!

Mid-Afternoon Market Update: Cubic Tumbles Following Q4 Results; Hepion Pharmaceuticals Shares Climb

Trucks Carried 70 Percent Of All US-Mexico Freight In September, Up $400 Million, According To Data